» Articles » PMID: 28693043

Sensitivity Analysis in Observational Research: Introducing the E-Value

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2017 Jul 11
PMID 28693043
Citations 1829
Authors
Affiliations
Soon will be listed here.
Abstract

Sensitivity analysis is useful in assessing how robust an association is to potential unmeasured or uncontrolled confounding. This article introduces a new measure called the "E-value," which is related to the evidence for causality in observational studies that are potentially subject to confounding. The E-value is defined as the minimum strength of association, on the risk ratio scale, that an unmeasured confounder would need to have with both the treatment and the outcome to fully explain away a specific treatment-outcome association, conditional on the measured covariates. A large E-value implies that considerable unmeasured confounding would be needed to explain away an effect estimate. A small E-value implies little unmeasured confounding would be needed to explain away an effect estimate. The authors propose that in all observational studies intended to produce evidence for causality, the E-value be reported or some other sensitivity analysis be used. They suggest calculating the E-value for both the observed association estimate (after adjustments for measured confounders) and the limit of the confidence interval closest to the null. If this were to become standard practice, the ability of the scientific community to assess evidence from observational studies would improve considerably, and ultimately, science would be strengthened.

Citing Articles

Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas.

Chen W, Lin T, Chang Y, Shen Y, Hsu H, Kuo T Clin Transl Sci. 2025; 18(3):e70177.

PMID: 40075548 PMC: 11903325. DOI: 10.1111/cts.70177.


Sex differences in the relationship between body mass index in Chinese adolescents and future risk of hypertension: a decade-long cohort study.

Liu R, Hu H, Cao C, Han Y, Bai Y, Feng W BMC Pediatr. 2025; 25(1):187.

PMID: 40069609 PMC: 11900636. DOI: 10.1186/s12887-025-05555-2.


Association between estimated glucose disposal rate and incident cardiovascular disease in a population with Cardiovascular-Kidney-Metabolic syndrome stages 0-3: insights from CHARLS.

Tan Z, Zhou D, Tang Y, Huo G Front Cardiovasc Med. 2025; 12:1537774.

PMID: 40066350 PMC: 11891229. DOI: 10.3389/fcvm.2025.1537774.


Effectiveness of phosphate binders on mortality and cardiovascular disease in end-stage renal disease patients with hyperphosphatemia: a multicenter real-world cohort study.

Chaiyakittisopon K, Pattanaprateep O, Ponthongmak W, Kunakorntham P, Chuasuwan A, Ingsathit A BMC Nephrol. 2025; 26(1):131.

PMID: 40065267 PMC: 11895186. DOI: 10.1186/s12882-025-04058-7.


Improvement in long-term survival with mesenchymal stem cell transplantation in systemic sclerosis patients: a propensity score-matched cohort study.

Yuan W, Liu M, Yang D, Shi Y, Wang Z, Cao X Stem Cell Res Ther. 2025; 16(1):128.

PMID: 40059221 PMC: 11892273. DOI: 10.1186/s13287-025-04237-1.